ClinicalTrials.Veeva

Menu

Korean Hereditary Breast Cancer Study (KOHBRA)

K

Korean Breast Cancer Study Group

Status

Unknown

Conditions

Breast Cancer
Ovarian Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT00595348
Sung-Won Kim, brca@korea.com
KBCSG003

Details and patient eligibility

About

  1. To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients with family history of breast/ovarian cancer.
  2. To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients without family history, but high risk of hereditary cancer.
  3. To evaluate the prevalence of BRCA1/2 mutation of family member of BRCA1/2 mutation.
  4. To evaluate the prevalence of ovarian cancer of population of above 3 groups.

Full description

  1. To find founder mutation in Korean
  2. To correlation prevalence with risk evaluation
  3. To find risk factors concerning life style

Enrollment

2,250 estimated patients

Sex

All

Ages

20+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Over 19 years old
  • Agree to this study
  • Breast cancer patient with family history of breast/ovarian cancer (1 subgroup)
  • Breast cancer patient; young age (<40), bilateral, male, combined ovarian (2 subgroup)
  • Family members with 1, 2 subgroups (3 subgroup)

Exclusion criteria

  • Under 20 years old
  • Unable to decide for oneself

Trial contacts and locations

1

Loading...

Central trial contact

Ku Sang Kim, M.D, AME.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems